Biography: Undurti Narasimha Das (Born 1950) Is An Indian Clinical Immunologist, Endocrinoloist and The
Biography: Undurti Narasimha Das (Born 1950) Is An Indian Clinical Immunologist, Endocrinoloist and The
Biography: Undurti Narasimha Das (Born 1950) Is An Indian Clinical Immunologist, Endocrinoloist and The
founder president and chief executive officer of UND Life Sciences.[1] An elected fellow of
the National Academy of Medical Sciences,[2] Das is known for his researches in the fields
of Immunology, Endocrinology and Rheumatology.[3] He holds a number of patents for his
work[4] The Council of Scientific and Industrial Research, the apex agency of the Government of India
for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology,
one of the highest Indian science awards for his contributions to Medical Sciences in 1992. [5]
Contents
[hide]
1Biography
2Legacy
4Selected bibliography
o 4.1Books
o 4.2Articles
o 4.3Reviews
o 4.4Patents
5See also
6Notes
7References
8External links
Biography[edit]
Legacy[edit]
Glioma MRI
Researches of U. N. Das are focused on various disease processes and his researches have
revealed the tumoricidal properties of cis-unsaturated fatty acids as well as the role of gamma-
Linolenic acid in controlling the progress of glioma, a type of tumor which affects brain and spinal
cord.[12] He has also worked on drug development to combat diseases and conditions such as
obesity, cancer, diabetes, hypertension and schizophrenia.[13][14] His researches have been
documented by way of several articles;[15][note 1]ResearchGate an online repository of scientific articles
has listed 500 of them.[15] Besides, he has authored three books, viz. Metabolic Syndrome
Pathophysiology: The Role of Essential Fatty Acids,[16]Molecular Basis of Health and Disease[17][note
2]
and A Perinatal Strategy For Preventing Adult Disease: The Role of Long-Chain Polyunsaturated
Fatty Acids.[18] He holds a number of patents for his work, which include Method of potentating the
action of 2-methoxyoestradiol, statins and C-peptide of proinsulin,[19] Method(s) of stabilizing and
potentiating the actions and administration of brain-derived neurotrophic factor (BDNF) [20] Method of
stabilizing and potentiating the action of anti-angiogenic substances,[21] Method(s) of preventing,
arresting, reversing and treatment of atherosclerosis,[22] and Methods for selectively occluding blood
supplies to neoplasias[23] and Butyrylcholinesterase as a marker of low-grade systemic inflammation.
[24]
Das is the editor-in-chief of Lipids in Health and Disease, a journal published by BioMed
Central[25] and Current Nutrition & Food Science, published by Bentham Science.[26][note 3] He is the
section editor of Medicine journal,[27] a member of the editorial board of the Medical
Hypotheses[28] and the Journal of Geriatric Cardiology[29] and sits in the scientific advisory board of
Techno Scienze Publisher[30] which publishes a number of journals.[31] He is also a member of the
editorial review board of Journal of Applied Research in Clinical and Experimental
Therapeutics[32] and has been associated with a number of other journals as a member of their
editorial boards or the Panel of Reviewers which include World Journal of Diabetes,[33] European
Journal of General Medicine, Journal of the Association of Physicians of India, Frontiers in
Biosciences, Diabetes Review Letters, Open Colorectal Cancer Journal, Indian Journal of Medical
Research[34] and Gene Therapy and Molecular Biology.[6] He has also been a member of the
International Advisory Board of the II International Conference on Functional Foods for the
Prevention and Treatment of Chronic Diseases, organized by Functional Foods Center, held in
November, 2005 at Richardson, Texas;[35]